Panbela provides business update and reports q1 2022 financial results

Minneapolis, may 12, 2022 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla), a clinical stage company developing disruptive therapeutics for the treatment of patients with cancer, today provides a business update and reports financial results for the quarter ended march 31, 2022. management is hosting an earnings call today at 4:30 p.m. et.
PBLA Ratings Summary
PBLA Quant Ranking